FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
de Claro, R Angelo
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2015 - 3586-90 p. digital
Publication Type: Journal Article; Multicenter Study
1557-3265
10.1158/1078-0432.CCR-14-2225 doi
Adenine--analogs & derivatives
Aged
Clinical Trials as Topic
Drug Approval--legislation & jurisprudence
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Mantle-Cell--drug therapy
Male
Middle Aged
Piperidines
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--adverse effects
Pyrimidines--adverse effects
United States
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2015 - 3586-90 p. digital
Publication Type: Journal Article; Multicenter Study
1557-3265
10.1158/1078-0432.CCR-14-2225 doi
Adenine--analogs & derivatives
Aged
Clinical Trials as Topic
Drug Approval--legislation & jurisprudence
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Mantle-Cell--drug therapy
Male
Middle Aged
Piperidines
Protein Kinase Inhibitors--therapeutic use
Pyrazoles--adverse effects
Pyrimidines--adverse effects
United States